Covered recipient · General Payments record
LEAH M EBBEN
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant
General Payments · PY2022–2024
$5,079.96
- Reported across 40 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,761.34 | 22 |
| Travel and Lodging | $1,306.12 | 3 |
| Consulting Fee | $720.00 | 1 |
| Education | $89.95 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Genmab U.S., Inc. | $3,008.82 | 15 |
| ABBVIE INC. | $278.86 | 5 |
| Janssen Biotech, Inc. | $185.61 | 2 |
| PFIZER INC. | $119.22 | 1 |
| Acerta Pharma LLC | $103.38 | 1 |
| GENZYME CORPORATION | $85.04 | 1 |
| Novocure Inc. | $80.91 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $15.57 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (27)
Sorted by paying entity, then date · as published by CMS
Program year 2024 20222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $85.03 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107057800 | CMS |
| ABBVIE INC. | $23.68 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107057802 | CMS |
| ABBVIE INC. | $21.34 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107057804 | CMS |
| ABBVIE INC. | $24.08 | 07/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107057806 | CMS |
| ABBVIE INC. | $124.73 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107057808 | CMS |
| AstraZeneca Pharmaceuticals LP | $103.38 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104774184 | CMS |
| Genmab U.S., Inc. | $127.59 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1126837452 | CMS |
| Genmab U.S., Inc. | $62.82 | 03/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1126837450 | CMS |
| Genmab U.S., Inc. | $150.00 | 06/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1126837454 | CMS |
| Genmab U.S., Inc. | $116.11 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1126837456 | CMS |
| Genmab U.S., Inc. | $102.52 | 10/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1126837458 | CMS |
| Genmab U.S., Inc. | $113.96 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1126837464 | CMS |
| Genmab U.S., Inc. | $71.27 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1126837462 | CMS |
| Genmab U.S., Inc. | $838.95 | 11/13/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1126837466 | CMS |
| Genmab U.S., Inc. | $15.61 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1126837468 | CMS |
| Genmab U.S., Inc. | $423.57 | 11/13/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1126837472 | CMS |
| Genmab U.S., Inc. | $88.66 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1126837478 | CMS |
| Genmab U.S., Inc. | $32.03 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1126837460 | CMS |
| Genmab U.S., Inc. | $720.00 | 12/18/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1126837470 | CMS |
| Genmab U.S., Inc. | $43.60 | 12/18/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1126837474 | CMS |
| Genmab U.S., Inc. | $102.13 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1126837476 | CMS |
| GENZYME CORPORATION | $85.04 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139991361 | CMS |
| Janssen Biotech, Inc. | $95.66 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078836138 | CMS |
| Janssen Biotech, Inc. | $89.95 | 05/08/2024 | Education | Undisputed | 01/23/2026 | 1078836148 | CMS |
| Novartis Pharmaceuticals Corporation | $15.57 | 08/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086949853 | CMS |
| Novocure Inc. | $80.91 | 10/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1123337036 | CMS |
| PFIZER INC. | $119.22 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131468203 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.